Role of catecholamines in fatal hyperpyrexia induced by imipramine in MAOI treated rabbits.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000502:physiology*; D002714:Chlorisondamine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004336:Drug Antagonism; D005260:Female; D005334:Fever / Q000139:chemically induced* / Q000401:mortality; D007031:Hypothalamus / Q000502:physiology; D007099:Imipramine / Q000037:antagonists & inhibitors / Q000633:toxicity*; D008297:Male; D009526:Nialamide / Q000037:antagonists & inhibitors / Q000633:toxicity*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D010643:Phenoxybenzamine; D012110:Reserpine; D011433:Propranolol; D002714:Chlorisondamine; D007099:Imipramine; D009526:Nialamide; D002746:Chlorpromazine